RESOURCES

Blogs

Insight at the intersection of data science and real-world health

The Talking Room

Demystifying AI, LLMs and machine learning

Use Cases

How teams put the signals to work

Compliance Hub

Data integrity, ethical AI and regulatory standards

DrugVoice

Built to be defensible.

Compliance, ethics, and data integrity are part of the process.

TMLABS

About us

Where our proprietary models are trained, tested and refined

Articles & scientific publications

Peer-reviewed methodologies and validated outcomes

Latest paper

The New GLP-1 Consumer

Articles & Scientific Publications

DRUGVOICE

DrugVoice

Measure how your messaging lands and evidence what moved

SEE IT IN ACTION

Bring us a question you can’t answer.

We’ll show you what the conversation already contains, using your therapy area and your audience.

ABOUT US

About us

Where our proprietary models are trained, tested and refined

ESG

Responsible innovation and ethical data practice

WHO WE ARE

Data scientists who speak pharma.

A team built around one problem: making real-world conversation usable at scale.

Revolutionizing Market Research with DrugVoice Summaries
Download

At a Glance

Challenges

  • Unable to structure data efficently and effectively through traditional research methods
  • Time for manual analysis of related real-world conversations
  • Unable to readily perform comparisons between transcripts and groups of transcripts

Benefits

  • Rapid structure of Conversational Data
  • Compare summaries and answers from different authors
  • Drives internal efficiency
  • Tailored insights and comparisons

Customer Objective

A leading Market Research Agency were hired to interview 300 HCPs based in the US. They needed to collate the research and analyze the data in a timely manner to understand what the key topics of discussion were and answer key questions their pharma client had around the emerging landscape of Sjogren’s Syndrome and Systemic Lupus Erythematosus treatments.

Brief

The agency faced challenges in effectively and efficiently structuring their Conversational Data from transcripts. To understand key topics and answer critical questions about the emerging landscape of treatments for Sjogren’s Syndrome and Systemic Lupus Erythematosus, they used DrugVoice to curate intelligence from their HCP interview transcripts.

Solution

Summarization was used to condense the information from the transcripts to highlight the most important pieces of information, at a per-transcript level, and across all transcripts, but also to summarize information relating to specific topics of interest. DrugVoice was then used to extract further intelligence from the data relating to the specific client questions asked.

By leveraging DrugVoice, the Customer was able to rapidly structure Conversational Data, resulting in a comprehensive view of the information at a per-transcript level, across all transcripts or across subpopulations of interest e.g. HCPs from one country versus another. The Customer was also able to compare summaries and answers from different subpopulations. Overall, this approach led to an 80% time efficiency improvement.

Understand the nuances within Conversational Data with DrugVoice

Contact Britt Gibson, Manager Global Customer Engagement, at britt@talkingmedicines.com.

Read More

#
$